Table 3 Proportions of diagnostic evaluation among patients who had contacted their general practitioner (GP) about at least one lung cancer symptom.

From: Changes in diagnostic evaluation of patients with lung cancer symptoms

 

Total imaging

First choice of imaging

 

Chest X-ray

CT of the thorax

2012 (N = 2538)

2022 (N = 2229)

 

2012 (N = 2538)

2022 (N = 2229)

 

2012 (N = 2538)

2022 (N = 2229)

 

n (%)

n (%)

p-valuea

n (%)

n (%)

p-valuea

n (%)

n (%)

p-valuea

Total

613 (24.2)

483 (21.7)

<0.01

552 (21.7)

332 (14.9)

<0.001

61 (2.4)

151 (6.8)

<0.001

Sex

  

0.05

  

0.03

  

0.32

 Females

304 (23.5)

268 (21.1)

 

275 (21.3)

185 (14.6)

 

29 (2.2)

83 (6.5)

 

 Males

309 (24.8)

215 (22.4)

 

277 (22.2)

147 (15.3)

 

32 (2.6)

68 (7.1)

 

Age groups

  

0.03

  

<0.01

  

0.18

 40-54 years

142 (22.6)

81 (17.2)

 

121 (19.3)

49 (10.4)

 

≤3

23 (4.9)

 

 55-69 years

521 (30.2)

409 (25.8)

 

389 (22.5)

252 (15.9)

 

≤3

114 (7.2)

 

 70+ years

67 (36.8)

62 (35.2)

 

42 (23.1)

31 (17.6)

 

≤3

14 (8.0)

 

Smoking status

  

<0.01

  

<0.01

  

0.51

 Never

156 (20.2)

163 (18.8)

 

139 (18.0)

109 (12.6)

 

18 (2.3)

54 (6.2)

 

 Former

304 (27.2)

244 (24.2)

 

273 (24.4)

173 (17.1)

 

30 (2.7)

71 (7.0)

 

 Current

153 (23.6)

76 (21.5)

 

140 (21.6)

50 (14.1)

 

15 (2.3)

26 (7.3)

 

Symptom burden

  

0.02

  

0.05

  

0.56

 1 symptom

392 (22.0)

293 (19.9)

 

350 (19.7)

199 (13.5)

 

43 (2.4)

94 (6.4)

 

 2 symptoms

161 (26.1)

158 (25.7)

 

148 (24.0)

115 (18.7)

 

15 (2.4)

43 (7.0)

 

 ≥3 symptoms

60 (41.7)

32 (23.0)

 

54 (37.5)

18 (12.9)

 

5 (3.5)

14 (10.1)

 

Single symptoms

         

 Prolonged coughing

334 (26.3)

298 (22.9)

0.02

139 (18.0)

109 (12.6)

0.05

20 (1.6)

87 (6.7)

<0.01

 Dyspnea

415 (25.7)

311 (22.3)

0.25

367 (22.7)

212 (15.2)

0.42

48 (3.0)

99 (7.1)

0.06

 Heamoptysis

16 (69.6)

16 (43.2)

0.49

≤3

9 (24.3)

0.87

≤3

7 (18.9)

0.66

 Prolonged hoarseness

129 (24.2)

82 (20.7)

0.09

113 (21.2)

52 (13.1)

0.07

16 (3.0)

30 (7.6)

0.31

  1. aTested for difference using Chi Square test, statistically significance level 0.05.
  2. Numbers ≤3 cannot be shown due to Danish Data Legislation.